Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Classical Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03907488
What this trial is testing

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Lymphocyte-Depleted Classic Hodgkin LymphomaAnn Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma+7 more
National Cancer Institute (NCI) 994
Testing effectiveness (Phase 2)Looking for participantsNCT07021989
What this trial is testing

CtDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRefractory Hodgkin LymphomaClassic Hodgkin Lymphoma
Michael Spinner, MD 38
Large-scale testing (Phase 3)Study completedNCT07450508
What this trial is testing

Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma Relapsed
Cairo University 88
Large-scale testing (Phase 3)Ended earlyNCT00005090
What this trial is testing

S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

Who this might be right for
Lymphoma
SWOG Cancer Research Network 11
Large-scale testing (Phase 3)Ended earlyNCT04486391
What this trial is testing

Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
BeiGene 3
Testing effectiveness (Phase 2)Study completedNCT03209973
What this trial is testing

Tislelizumab as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
BeiGene 70
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Early research (Phase 1)Active Not RecruitingNCT04288726
What this trial is testing

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

Who this might be right for
Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeClassical Hodgkin Lymphoma
Baylor College of Medicine 27
Testing effectiveness (Phase 2)UnknownNCT04624984
What this trial is testing

PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL

Who this might be right for
Classical Hodgkin LymphomaRefractory or Relapsed Classical Hodgkin Lymphoma
Sun Yat-sen University 42
Testing effectiveness (Phase 2)Study completedNCT02181738
What this trial is testing

Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

Who this might be right for
Hodgkin Disease
Bristol-Myers Squibb 294
Testing effectiveness (Phase 2)Looking for participantsNCT07275216
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment

Who this might be right for
Classic Hodgkin Lymphoma
City of Hope Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT02191930
What this trial is testing

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 70
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Not applicableLooking for participantsNCT03280394
What this trial is testing

Liquid Biopsy in Mature B-cell Tumors

Who this might be right for
Mature B-Cell Neoplasm
Oncology Institute of Southern Switzerland 444
Testing effectiveness (Phase 2)Looking for participantsNCT04510636
What this trial is testing

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaRelapsed CancerRefractory Cancer
University Health Network, Toronto 40
Testing effectiveness (Phase 2)UnknownNCT03077828
What this trial is testing

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Lymphocyte-Rich Classical Hodgkin LymphomaRecurrent Lymphocyte-Depleted Classical Hodgkin LymphomaRecurrent Mixed Cellularity Classical Hodgkin Lymphoma+4 more
Northwestern University 43
Testing effectiveness (Phase 2)UnknownNCT05900765
What this trial is testing

Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Sun Yat-sen University 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938232
What this trial is testing

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

Who this might be right for
Hodgkin LymphomaRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Dana-Farber Cancer Institute 13
Next Page